Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:50 AM UTC
| NCT Number | NCT06330064 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE1 |
| Target Enrollment | 680 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Daiichi Sankyo |
| Last Updated on CT.gov | August 5, 2026 (3 weeks ago) |
As of August 28, 2026: Clinical trial NCT06330064 is currently recruiting participants. This phase1 study for cancer is actively seeking new participants at 18 locations across the United States. The study is sponsored by Daiichi Sankyo. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06330064 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06330064 was last updated 3 weeks ago (August 5, 2026). HelloStudys verifies this status automatically.